Merck KGaA (MKKGY)
31.77
-0.67
(-2.07%)
USD |
OTCM |
Apr 25, 09:39
Merck Total Assets (Quarterly): 53.61B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 53.61B |
| September 30, 2023 | 52.83B |
| June 30, 2023 | 53.01B |
| March 31, 2023 | 53.04B |
| December 31, 2022 | 52.05B |
| September 30, 2022 | 50.06B |
| June 30, 2022 | 50.89B |
| March 31, 2022 | 51.60B |
| December 31, 2021 | 51.36B |
| September 30, 2021 | 50.85B |
| June 30, 2021 | 51.34B |
| March 31, 2021 | 51.45B |
| December 31, 2020 | 51.41B |
| September 30, 2020 | 50.76B |
| June 30, 2020 | 49.29B |
| March 31, 2020 | 49.35B |
| December 31, 2019 | 49.07B |
| September 30, 2019 | 46.03B |
| June 30, 2019 | 44.99B |
| March 31, 2019 | 43.48B |
| December 31, 2018 | 42.20B |
| September 30, 2018 | 41.53B |
| June 30, 2018 | 41.42B |
| March 31, 2018 | 43.37B |
| December 31, 2017 | 42.73B |
| Date | Value |
|---|---|
| September 30, 2017 | 42.21B |
| June 30, 2017 | 42.07B |
| March 31, 2017 | 40.98B |
| December 31, 2016 | 40.44B |
| September 30, 2016 | 41.22B |
| June 30, 2016 | 41.19B |
| March 31, 2016 | 42.13B |
| December 31, 2015 | 41.63B |
| September 30, 2015 | 36.30B |
| June 30, 2015 | 33.43B |
| March 31, 2015 | 33.31B |
| December 31, 2014 | 31.63B |
| September 30, 2014 | 28.83B |
| June 30, 2014 | 29.30B |
| March 31, 2014 | 28.89B |
| December 31, 2013 | 28.75B |
| September 30, 2013 | 28.78B |
| June 30, 2013 | 28.40B |
| March 31, 2013 | 28.13B |
| December 31, 2012 | 28.62B |
| September 30, 2012 | 28.76B |
| June 30, 2012 | 27.24B |
| March 31, 2012 | 28.61B |
| December 31, 2011 | 28.65B |
| September 30, 2011 | 30.42B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.99B
Minimum
Jun 2019
53.61B
Maximum
Dec 2023
50.68B
Average
51.34B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Affimed NV | 107.40M |
| InflaRx NV | 132.88M |
| MorphoSys AG | 2.240B |
| BioNTech SE | 25.43B |
| Immatics NV | 563.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.03B |
| Shareholders Equity (Quarterly) | 29.49B |
| Debt to Equity Ratio | 0.3504 |
| Current Ratio | 1.425 |
| Net Debt Paydown Yield | 0.15% |